AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 17.5

Change

0.00 (0.00)%

Market Cap

USD 11.92B

Volume

0.02B

Analyst Target

USD 23.81
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-09 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 65.91B
ALC Alcon AG

N/A

USD 46.01B
RMD ResMed Inc

N/A

USD 34.14B
BAX Baxter International Inc

N/A

USD 18.71B
ATR AptarGroup Inc

N/A

USD 10.16B
TFX Teleflex Incorporated

N/A

USD 7.78B
STVN Stevanato Group SpA

N/A

USD 5.98B
BLCO Bausch + Lomb Corp

N/A

USD 5.64B
WRBY Warby Parker Inc

N/A

USD 3.17B
INFU InfuSystems Holdings Inc

N/A

USD 0.17B

ETFs Containing AVTR

COPP Sprott Copper Miners ETF 10.10 % 0.00 %

N/A

N/A
CEBS:XETRA iShares Copper Miners UCI.. 5.61 % 0.00 %

N/A

USD 0.05B
COPX Global X Copper Miners ET.. 5.42 % 0.65 %

N/A

USD 2.69B
COPG:LSE Global X Copper Miners UC.. 5.23 % 0.00 %

N/A

USD 0.16B
4COP:XETRA Global X Copper Miners UC.. 5.13 % 0.00 %

N/A

USD 0.09B
WIRE:AU Global X Copper Miners ET.. 5.04 % 0.00 %

N/A

N/A
XMET:AU BetaShares Energy Transit.. 4.85 % 0.00 %

N/A

N/A
COPX:SW Global X Copper Miners UC.. 4.56 % 0.00 %

N/A

N/A
D6AT:XETRA Global X Disruptive Mater.. 4.46 % 0.00 %

N/A

N/A
COPX:LSE Global X Copper Miners UC.. 4.31 % 0.00 %

N/A

N/A
GMTL:AU Global X Green Metal Mine.. 4.18 % 0.00 %

N/A

N/A
SETM:LSE 3.14 % 0.00 %

N/A

N/A
BSJO 0.00 % 0.42 %

N/A

N/A
IVOV Vanguard S&P Mid-Cap 400 .. 0.00 % 0.20 %

N/A

USD 0.94B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

N/A

USD 0.19B
PQIN 0.00 % 0.00 %

N/A

N/A
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
EXV6:F 0.00 % 0.00 %

N/A

N/A
EXV6:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.37B
CRIT Optica Rare Earths & Crit.. 0.00 % 0.00 %

N/A

USD 3.36M
BRHY BlackRock High Yield ETF 0.00 % 0.00 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.94% 26% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.94% 26% F 9% A-
Trailing 12 Months  
Capital Gain -31.75% 26% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -31.75% 26% F 7% C-
Trailing 5 Years  
Capital Gain 26.54% 69% C- 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.54% 63% D 40% F
Average Annual (5 Year Horizon)  
Capital Gain 10.63% 74% C 66% D+
Dividend Return 10.63% 74% C 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 46.43% 37% F 20% F
Risk Adjusted Return 22.90% 68% D+ 37% F
Market Capitalization 11.92B 71% C- 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector